When team Avisi recently stepped into an operating room at Penn, the setting was familiar. Years earlier, founder and CEO Rui Jing Jiang W’18 and her fellow student founders had stood in rooms like it to observe glaucoma surgeries while designing a new device to treat the degenerative eye disease.…Read More
The company, cofounded by Wharton alumni, will use the National Science Foundation award to continue pursuing its innovative glaucoma treatment.…Read More
The winners of Penn’s 5th annual Y-Prize Competition, Avisi Technologies, have secured a $225,000 National Science Foundation grant to continue developing their eye implant VisiPlate.…Read More
The team will receive $250K to help them bring their revolutionary glaucoma treatment to market.…Read More
Penn’s 2017 Y-Prize winner proposed using ultrathin aluminum oxide implants to release eye pressure that leads to irreversible optic nerve damage.…Read More
The finalists in this year’s Y-Prize Competition have proposed ideas that would improve greenhouses, expedite heat removal in electronics, block sun from cars windows, and even defend against glaucoma.…Read More
